Before I truly settled on my research interest, I explored various academic fields. I started my undergraduate studies in aquaculture at Southwest University, which led me to the Institute of Hydrobiology, Chinese Academy of Sciences for further education. Subsequently, I pursued my PhD degree in School of Biomedical Sciences at the Chinese University of Hong Kong (CUHK), specializing in cancer and inflammation research, a cross-disciplinary shift inspired by my leap curiosity about the mysteries of life. Under the guidance of Professor Yangchao Chen during my doctoral and postdoctoral studies at CUHK, I focused on tumor molecular biology, histone epigenetic regulation, and the targeting of microRNAs, lncRNAs, as well as the development and application of tumor immunotherapy technologies. Having witnessed numerous families struggle with high medical expenses during my life and academic pursuits, I made it my mission to turn my research findings into practical medical applications, aiming to alleviate the burden on patients through my work.

After graduation, led by Prof. Chi Hin Cho, an Emeritus Professor at the Chinese University of Hong Kong, we returned to Luzhou as a member of CUHK doctoral team. Equipped with the advanced technologies and concepts I acquired in Hong Kong, I dedicated to contribute to the medical advancements of my hometown.

In Luzhou, I established several key institutions, including the Molecular Pharmacology Laboratory, the South Sichuan Institute of Translational Medicine, the Luzhou Key Laboratory of Cell Therapy and Cell Pharmaceuticals and etc. These endeavors have brought cutting-edge technologies and talents to my hometown. I have also actively promoted collaborations with CUHK, signing Memorandum of Understanding (MOU) with School of Biomedical Sciences, Faculty of Medicine to establish a new platform for tumor immunotherapy. Together, we are driving the development of tumor immunotherapy technologies, working diligently to facilitate the translational research achievements and bringing new hope to cancer patients. These platforms not only provide a robust foundation for our research team but also serve as powerful catalysts for medical technological advancements in Luzhou and throughout southern Sichuan region.

Looking back, I feel that every step I have taken has been solid and determined. Moving forward, I will continue to delve deep into scientific research, making cancer less daunting. On this long and arduous journey, my team and I will remain steadfast, embodying our passion for science and respect for life.

Dr. Xiao Zhangang (left) and his supervisor Prof. Chen Yangchao (right)

Dr. Xiao Zhangang (3rd from right) and his doctoral team from CUHK